Details
Cardiac transthyretin #amyloidosis (ATTR-CM) is a progressive and often fatal heart disease caused by misfolded #transthyretin buildup in the heart, with limited treatments like Tafamidis slowing progression.
Emerging research from scientists in Germany, supported by StressMarq's #TTR PFFs, suggests that both naturally occurring and engineered antibodies could help to clear #amyloid deposits.